Literature DB >> 18550677

Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.

Andreas Oliver Weinzierl1, Gudrun Szalay, Hartwig Wolburg, Martina Sauter, Hans-Georg Rammensee, Reinhard Kandolf, Stefan Stevanović, Karin Klingel.   

Abstract

Enteroviruses such as coxsackievirus B3 (CVB3) are able to induce lethal acute and chronic myocarditis. In resistant C57BL/6 mice, CVB3 myocarditis is abrogated by T-cell-dependent mechanisms, whereas major histocompatibility complex (MHC)-matched permissive A.BY/SnJ mice develop chronic myocarditis based on virus persistence. To define the role of T-cell-priming dendritic cells (DCs) in the outcome of CVB3 myocarditis, DCs were analyzed in this animal model in the course of CVB3 infection. In both mouse strains, DCs were found to be infectible with CVB3; however, formation of infectious virions was impaired. In DCs derived from C57BL/6 mice, significantly higher quantities of interleukin-10 (IL-10) and the proinflammatory cytokines IL-6 and tumor necrosis factor alpha were measured compared to those from A.BY/SnJ mice. Additionally, the chemokines interferon-inducible protein 10 (IP-10) and RANTES were secreted by DCs from resistant C57BL/6 mice earlier in infection and at significantly higher levels. The protective role of IP-10 in CVB3 myocarditis was confirmed in IP-10(-/-) mice, which had increased myocardial injury compared to the immunocompetent control animals. Also, major differences in resistant and permissive mice were found in DC subsets, with C57BL/6 mice harboring more cross-priming CD4(-) CD8(+) DCs. As CD4(-) CD8(+) DCs are known to express 10 times more Toll-like receptor 3 (TLR3) than other DC subsets, we followed the course of CVB3 infection in TLR3(-/-) mice. These mice developed a fulminant acute myocarditis and secreted sustained low amounts of type I interferons; secretion of IP-10 and RANTES was nearly abrogated in DCs. We conclude that MHC-independent genetic factors involving DC-related IP-10 secretion and TLR3 expression are beneficial in the prevention of chronic coxsackievirus myocarditis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550677      PMCID: PMC2519575          DOI: 10.1128/JVI.00047-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Cutting Edge: Antibody-mediated TLR7-dependent recognition of viral RNA.

Authors:  Jennifer P Wang; Damon R Asher; Melvin Chan; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

Review 2.  Regulatory T cells and infection: a dangerous necessity.

Authors:  Yasmine Belkaid
Journal:  Nat Rev Immunol       Date:  2007-11       Impact factor: 53.106

3.  Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury.

Authors:  Hordur S Hardarson; J Scott Baker; Zhao Yang; Enkhsaikhan Purevjav; Chien-Hua Huang; Lena Alexopoulou; Na Li; Richard A Flavell; Neil E Bowles; Jesus G Vallejo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-08-25       Impact factor: 4.733

4.  Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production.

Authors:  L J Ho; J J Wang; M F Shaio; C L Kao; D M Chang; S W Han; J H Lai
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

5.  Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus.

Authors:  Matias Ostrowski; Monica Vermeulen; Osvaldo Zabal; Jorge R Geffner; Ana M Sadir; Osvaldo J Lopez
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

6.  Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.

Authors:  Koichi Fuse; Grace Chan; Youan Liu; Patrick Gudgeon; Mansoor Husain; Manyin Chen; Wen-Chen Yeh; Shizuo Akira; Peter P Liu
Journal:  Circulation       Date:  2005-10-11       Impact factor: 29.690

7.  Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.

Authors:  Gudrun Szalay; Martina Sauter; Joachim Hald; Andreas Weinzierl; Reinhard Kandolf; Karin Klingel
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

8.  Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.

Authors:  Ming-Fang Hsieh; Szu-Liang Lai; Jia-Perng Chen; Jui-Ming Sung; Yi-Ling Lin; Betty A Wu-Hsieh; Craig Gerard; Andrew Luster; Fang Liao
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

9.  Polyinosinic acid is a ligand for toll-like receptor 3.

Authors:  Stuart Marshall-Clarke; Joan E Downes; Ismar R Haga; Andrew G Bowie; Persephone Borrow; Joanne L Pennock; Richard K Grencis; Paul Rothwell
Journal:  J Biol Chem       Date:  2007-06-14       Impact factor: 5.157

10.  CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system.

Authors:  Jeanette Erbo Christensen; Carina de Lemos; Torben Moos; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

View more
  35 in total

Review 1.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

Review 2.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 3.  Cardiovascular inflammation: RNA takes the lead.

Authors:  Colton R Martens; Shyam S Bansal; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000

4.  Cell-type specificity and functional redundancy of RIG-I-like receptors in innate immune sensing of Coxsackievirus B3 and encephalomyocarditis virus.

Authors:  Esther Francisco; Mehul Suthar; Michael Gale; Amy B Rosenfeld; Vincent R Racaniello
Journal:  Virology       Date:  2018-12-11       Impact factor: 3.616

Review 5.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

6.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

7.  Direct gene transfer with IP-10 mutant ameliorates mouse CVB3-induced myocarditis by blunting Th1 immune responses.

Authors:  Yan Yue; Jun Gui; Wenqing Ai; Wei Xu; Sidong Xiong
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

Review 8.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis.

Authors:  Nicole L Kallewaard; Lili Zhang; Jin-Wen Chen; Marta Guttenberg; Melissa D Sanchez; Jeffrey M Bergelson
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

10.  Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.

Authors:  Christopher C Kemball; Stephanie Harkins; Jason K Whitmire; Claudia T Flynn; Ralph Feuer; J Lindsay Whitton
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.